Overview

Viagra in the Treatment of Primary Dysmenorrhea

Status:
Completed

Trial end date:
2011-08-01

Target enrollment:

Participant gender:

Summary

The primary hypothesis is that a 100mg single dose of sildenafil citrate (Viagra) will have a higher improvement rate when compared to placebo in the treatment of moderate to severe primary dysmenorrhea.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Milton S. Hershey Medical Center

Collaborator:

National Institutes of Health (NIH)

Treatments:

Citric Acid
Sildenafil Citrate